rs149250098
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136193.2(FASTKD2):c.356C>T(p.Ser119Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000948 in 1,613,900 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001136193.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FASTKD2 | NM_001136193.2 | c.356C>T | p.Ser119Phe | missense_variant | 2/12 | ENST00000402774.8 | |
FASTKD2 | NM_001136194.2 | c.356C>T | p.Ser119Phe | missense_variant | 2/12 | ||
FASTKD2 | NM_014929.4 | c.356C>T | p.Ser119Phe | missense_variant | 2/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FASTKD2 | ENST00000402774.8 | c.356C>T | p.Ser119Phe | missense_variant | 2/12 | 1 | NM_001136193.2 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000164 AC: 25AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000957 AC: 24AN: 250882Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135764
GnomAD4 exome AF: 0.0000876 AC: 128AN: 1461696Hom.: 1 Cov.: 32 AF XY: 0.000100 AC XY: 73AN XY: 727150
GnomAD4 genome ? AF: 0.000164 AC: 25AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74360
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jul 12, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 08, 2019 | Identified in the compound heterozygous state with another FASKD2 variant in a patient with myopathy in published literature (Nogueira et al., 2019); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30831263) - |
Combined oxidative phosphorylation deficiency 44 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 12, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at